Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.176.3.1331PMID 16424159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients

  2004cited by this paper
• Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes.

  2003cited by this paper
• Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.

  2003cited by this paper
• Procaspase-3 and its active large subunit localized in both cytoplasm and nucleus are activated following application of apoptotic stimulus in Ramos-Burkitt lymphoma B cells.

  2003cited by this paper
• Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway.

  2003cited by this paper
• Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

  2003cited by this paper
• Expression of HLA-G in human cornea, an immune-privileged tissue.

  2003cited by this paper
• HLA-G modulates immune responses by diverse receptor interactions.

  2003cited by this paper
• The Complexity of Tumor Vascularity

  2003cited by this paper
• HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.

  2003cited by this paper
• Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.

  2003cited by this paper
• Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8 Cells by Fas/Fas-Ligand Interaction

  2002influential reference
• Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection

  2002cited by this paper
• A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape1

  2002cited by this paper
• Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism

  2001cited by this paper
• p27Kip1 Regulates T Cell Proliferation*

  2001cited by this paper
• Liver-Derived Dendritic Cells Induce Donor-Specific Hyporesponsiveness: Use of Sponge Implant as a Cell Transplant Model

  2001cited by this paper
• HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.

  2001cited by this paper
• HLA-G suppresses proliferation of CD4(+) T-lymphocytes.

  2000cited by this paper
• Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

  2000cited by this paper
• Cytokine-Stimulated T Lymphocyte Proliferation Is Regulated by p27Kip1 1

  2000cited by this paper
• The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1

  2000cited by this paper
• Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD81

  2000influential reference
• Implication of HLA-G molecule in heart-graft acceptance.

  2000cited by this paper
• HLA‐G inhibits the transendothelial migration of human NK cells

  2000cited by this paper
• The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells

  1999cited by this paper
• HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes.

  1999cited by this paper
• Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.

  1999cited by this paper
• A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells

  1999cited by this paper
• HLA-G inhibits the allogeneic proliferative response.

  1999cited by this paper
• Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.

  1998cited by this paper
• Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin.

  1998influential reference
• The a1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?

  1997cited by this paper
• Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts

  1997cited by this paper
• The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

  1997cited by this paper
• Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors

  1997influential reference
• A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.

  1997influential reference
• A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

  1994cited by this paper
• Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

  1992cited by this paper
• Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody.

  1990cited by this paper

• Genetic variants of the HLA-G/LILRB1 ligand-receptor axis in donors or recipients are prognostic covariates for rejection after living kidney transplantation

  2026cites this paper
• Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation

  2025cites this paper
• Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma

  2025cites this paper
• The Biological Significance of Trogocytosis.

  2024cites this paper
• Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects

  2024cites this paper
• Human leukocyte immunoglobulin-like receptors in health and disease

  2023cites this paper
• Human leukocyte antigen‐G in gynaecological tumours

  2023cites this paper
• Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients

  2023cites this paper
• The correlation between soluble human leukocyte antigen (sHLA‐G) levels and +3010 polymorphism

  2023cites this paper
• Generation of a blockage monoclonal antibody of LILRB1 against HLA-G.

  2023cites this paper
• HLA Class Ib-receptor interactions during embryo implantation and early pregnancy.

  2022cites this paper
• HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia

  2022cites this paper
• HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease

  2022cites this paper
• The HLA-G immune checkpoint: a new immuno-stimulatory role for the α1-domain-deleted isoform

  2022cites this paper
• Regulatory Function of HLA-G in Maternal-Fetal Interface

  2022influential citation
• Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC

  2021cites this paper
• The HLA-G Immune Checkpoint Plays a Pivotal Role in the Regulation of Immune Response in Autoimmune Diseases

  2021cites this paper
• Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis.

  2021cites this paper
• HLA-G, cytokines, and cytokine receptors in the non-aggressive basal cell carcinoma microenvironment

  2021cites this paper
• Role and expression of non-classical human leukocyte antigen-G in renal transplanted allografts

  2021cites this paper
• HLA-G Neo-Expression on Tumors

  2020cites this paper
• Differential Activation of Immune Cells for Genetically Different Decellularized Cardiac Tissues

  2020cites this paper
• HLA-G +3196 polymorphism as a risk factor for cell mediated rejection following heart transplant.

  2020cites this paper
• The HLA-G 14 bp allele frequency in different populations: A global meta-analysis

  2020cites this paper
• The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells

  2020cites this paper
• Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane‐bound and secreted β2m‐HLA‐G fusion proteins

  2020cites this paper
• High level of soluble human leukocyte antigen (HLA)-G at beginning of pregnancy as predictor of risk of malaria during infancy

  2019cites this paper
• The Effect of Mesenchymal Stem Cells on the Expression of IDO and Qa2 Molecules in Dendritic Cells

  2019cites this paper
• Immune Modulation in HLA-G Expressing Head and Neck Squamous Cell Carcinoma in Relation to Human Papilloma Virus Positivity: A Study From Northeast India

  2019cites this paper
• Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G

  2019cites this paper
• Regulation of the anti-inflammatory properties of MSCspheroids by matrix metalloproteinases

  2019cites this paper
• The role of HLA‐G in parasitic diseases

  2018cites this paper
• New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy

  2018cites this paper
• 2 Distinctive Immunological Functions of HLA-G

  2018cites this paper
• Elevation of plasma-soluble HLA-G in childhood nephrotic syndrome is associated with IgE

  2017cites this paper
• Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells

  2017cites this paper
• HLA‐G regulatory polymorphisms are associated with susceptibility to HCV infection

  2017cites this paper
• Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

  2017cites this paper
• A soluble recombinant form of human leucocyte antigen-G 6 (srHLA-G6).

  2017cites this paper
• Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight

  2017cites this paper
• Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy

  2016cites this paper
• What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?

  2016cites this paper
• Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.

  2016cites this paper
• HLA-G genetic variants and hepatocellular carcinoma: a meta-analysis.

  2016cites this paper
• Trogocytic intercellular membrane exchanges among hematological tumors

  2015cites this paper
• Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis

  2015cites this paper
• HLA-G: An Immune Checkpoint Molecule.

  2015cites this paper
• Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.

  2015cites this paper
• The Relationship between HLA-G Gene Polymorphisms and Repeated Implantation Failure in Infertile Couples Undergoing Assisted Reproductive Technique.

  2015cites this paper
• Tolerogenic Mechanisms in Liver Transplantation

  2015cites this paper
• Serum antibodies to human leucocyte antigen (HLA)‐E, HLA‐F and HLA‐G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA‐F autoantibodies

  2015cites this paper
• [Not Available].

  2015cites this paper
• Utilisation des Cellules Souches Mésenchymateuses en transplantation d’organe.

  2015cites this paper
• The immunosuppressive potential of human amniotic membrane extract

  2015influential citation
• Soluble HLA-I/Peptide Monomers Mediate Antigen-Specific CD8 T Cell Activation through Passive Peptide Exchange with Cell-Bound HLA-I Molecules

  2014cites this paper
• Mutated HLA-G3 localizes to the cell surface but does not inhibit cytotoxicity of natural killer cells.

  2014cites this paper
• HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil.

  2014cites this paper
• Amnion-Derived Multipotent Progenitor Cells Inhibit Blood Monocyte Differentiation into Mature Dendritic Cells

  2014cites this paper
• In vivo evidence that secretion of HLA‐G by immunogenic tumor cells allows their evasion from immunosurveillance

  2014cites this paper
• HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy

  2014cites this paper
• Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.

  2014cites this paper
• Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection

  2014cites this paper
• Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Pro-Inflammatory Cytokine-Stimulated Human Corneal Epithelial Cells

  2014cites this paper
• HLA-E, HLA-F and HLA-G — The Non-Classical Side of the MHC Cluster

  2014cites this paper
• Cell-Bound HLA-I Molecules through Passive Peptide Exchange with Antigen-Specific CD 8 T Cell Activation Soluble HLA-I / Peptide Monomers Mediate

  2014cites this paper
• Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection

  2014cites this paper
• New insights into HLA-G mediated tolerance.

  2014cites this paper
• ANTIBODIES AND FRAGMENTS THEREOF RAISED AGAINST THE ALPHA-3

  2014cites this paper
• Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma.

  2014cites this paper
• Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation

  2014cites this paper
• molecule Beyond the increasing complexity of the immunomodulatory HLA-G

  2013cites this paper
• Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

  2013cites this paper
• Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection.

  2013cites this paper
• endothelial cell activation Expression and release of soluble HLA-E is an immunoregulatory feature of

  2013cites this paper
• Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population

  2013cites this paper
• HLA-G expression in the peripheral blood of live kidney transplant recipients.

  2013cites this paper
• β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.

  2013cites this paper
• The role of human leukocyte antigen G in immunological mechanisms and its clinical implication

  2013cites this paper
• HLA-G 2012 conference: the 15-year milestone update.

  2013cites this paper
• Synthetic HLA‐G proteins for therapeutic use in transplantation

  2013cites this paper
• The Role of Human Leukocyte Antigen-G in Cardiac Allograft Vasculopathy

  2013cites this paper
• Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors

  2012cites this paper
• The immunosuppressive molecule HLA-G and its clinical implications

  2012cites this paper
• Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies.

  2012cites this paper
• Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization.

  2012cites this paper
• Rola ludzkiego antygenu leukocytarnego G w procesach immunologicznych i jego znaczenie kliniczne

  2012cites this paper
• Human Leucocyte Antigen-G (HLA-G) dan Peranannya dalam Reproduksi

  2012cites this paper
• Distinctive Immunological Functions of HLA-G

  2012cites this paper
• New evidence for balancing selection at the HLA-G locus in South Amerindians

  2012cites this paper
• Characterization of Human Umbilical Cord Lining-Derived Epithelial Cells and Transplantation Potential

  2011cites this paper
• HLA-G: a look back, a look forward

  2011cites this paper
• The role of HLA-G in immunity and hematopoiesis

  2011cites this paper
• Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer

  2011cites this paper
• Dynamic Expression of Qa-2 during Acute Graft Rejection

  2011cites this paper
• Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo

  2011cites this paper
• Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation

  2011cites this paper
• Cell Transfer of Sensitivity - after Trogocytosis Allows a Functional Cell Proper Regrafting of Ig-Like Transcript 2

  2011cites this paper
• HLA-G in organ transplantation: towards clinical applications

  2011cites this paper
• 14-bp Insertion/Deletion Polymorphism of theHLA-GGene in Osteosarcoma Patients

  2011cites this paper
• Proper Regrafting of Ig-Like Transcript 2 after Trogocytosis Allows a Functional Cell–Cell Transfer of Sensitivity

  2011cites this paper